Erie Indemnity [ERIE] vs Marsh & McLennan [MMC] Detailed Stock Comparison
Erie Indemnity
NASDAQ
Loading...
Marsh & McLennan
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Erie Indemnity wins in 8 metrics, Marsh & McLennan wins in 11 metrics, with 0 ties. Marsh & McLennan appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Erie Indemnity | Marsh & McLennan | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.37 | 25.32 | Marsh & McLennan |
| Price-to-Book Ratio | 8.69 | 6.58 | Marsh & McLennan |
| Debt-to-Equity Ratio | 1.61 | 135.27 | Erie Indemnity |
| PEG Ratio | 4.65 | 3.21 | Marsh & McLennan |
| EV/EBITDA | 23.93 | 16.34 | Marsh & McLennan |
| Profit Margin (TTM) | 15.73% | 16.00% | Marsh & McLennan |
| Operating Margin (TTM) | 19.32% | 26.91% | Marsh & McLennan |
| EBITDA Margin (TTM) | 19.32% | 26.91% | Marsh & McLennan |
| Return on Equity | 31.14% | 28.41% | Erie Indemnity |
| Return on Assets (TTM) | 15.57% | 7.86% | Erie Indemnity |
| Free Cash Flow (TTM) | $486.40M | $3.99B | Marsh & McLennan |
| Dividend Yield | 1.86% | 1.51% | Erie Indemnity |
| 1-Year Return | -25.12% | -5.72% | Marsh & McLennan |
| Price-to-Sales Ratio (TTM) | 4.78 | 4.02 | Marsh & McLennan |
| Enterprise Value | $18.81B | $123.84B | Marsh & McLennan |
| EV/Revenue Ratio | 4.73 | 4.80 | Erie Indemnity |
| Gross Profit Margin (TTM) | N/A | 44.15% | N/A |
| Revenue per Share (TTM) | $76 | $52 | Erie Indemnity |
| Earnings per Share (Diluted) | $11.95 | $8.33 | Erie Indemnity |
| Beta (Stock Volatility) | 0.32 | 0.78 | Erie Indemnity |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Erie Indemnity vs Marsh & McLennan Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Erie Indemnity | 1.82% | -0.04% | 0.62% | 5.05% | -6.14% | -10.53% |
| Marsh & McLennan | -0.27% | 1.61% | 0.12% | -7.84% | -9.58% | -0.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Erie Indemnity | -25.12% | 68.29% | 76.55% | 343.11% | 601.97% | 596.37% |
| Marsh & McLennan | -5.72% | 26.87% | 84.69% | 288.97% | 778.76% | 680.68% |
Performance & Financial Health Analysis: Erie Indemnity vs Marsh & McLennan
| Metric | ERIE | MMC |
|---|---|---|
| Market Information | ||
| Market Cap | $18.98B | $103.70B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 135,263 | 2,292,330 |
| 90 Day Avg. Volume | 143,881 | 2,608,213 |
| Last Close | $366.36 | $210.55 |
| 52 Week Range | $332.34 - $547.00 | $196.27 - $248.00 |
| % from 52W High | -33.02% | -15.10% |
| All-Time High | $547.00 (Sep 23, 2024) | $248.00 (Mar 31, 2025) |
| % from All-Time High | -33.02% | -15.10% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.12% |
| Quarterly Earnings Growth | 0.07% | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | 0.16% |
| Operating Margin (TTM) | 0.19% | 0.27% |
| Return on Equity (TTM) | 0.31% | 0.28% |
| Debt to Equity (MRQ) | 1.61 | 135.27 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $41.78 | $32.07 |
| Cash per Share (MRQ) | $7.48 | $3.41 |
| Operating Cash Flow (TTM) | $688.32M | $4.92B |
| Levered Free Cash Flow (TTM) | $400.57M | $4.34B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.86% | 1.51% |
| Last 12-Month Dividend | $6.71 | $3.24 |
Valuation & Enterprise Metrics Analysis: Erie Indemnity vs Marsh & McLennan
| Metric | ERIE | MMC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.37 | 25.32 |
| Forward P/E | 27.09 | 22.37 |
| PEG Ratio | 4.65 | 3.21 |
| Price to Sales (TTM) | 4.78 | 4.02 |
| Price to Book (MRQ) | 8.69 | 6.58 |
| Market Capitalization | ||
| Market Capitalization | $18.98B | $103.70B |
| Enterprise Value | $18.81B | $123.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.73 | 4.80 |
| Enterprise to EBITDA | 23.93 | 16.34 |
| Risk & Other Metrics | ||
| Beta | 0.32 | 0.78 |
| Book Value per Share (MRQ) | $41.78 | $32.07 |
Financial Statements Comparison: Erie Indemnity vs Marsh & McLennan
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ERIE | MMC |
|---|---|---|
| Revenue/Sales | $1.22B | $7.06B |
| Cost of Goods Sold | N/A | $3.85B |
| Gross Profit | N/A | $3.21B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $2.01B |
| EBITDA | N/A | $2.29B |
| Pre-Tax Income | $174.75M | $1.83B |
| Income Tax | $36.33M | $415.00M |
| Net Income (Profit) | $138.42M | $1.41B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ERIE | MMC |
|---|---|---|
| Cash & Equivalents | $235.22M | $1.60B |
| Total Current Assets | N/A | $22.46B |
| Total Current Liabilities | N/A | $19.78B |
| Long-Term Debt | N/A | $20.43B |
| Total Shareholders Equity | $2.07B | $14.27B |
| Retained Earnings | $3.24B | $25.88B |
| Property, Plant & Equipment | N/A | $3.91B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ERIE | MMC |
|---|---|---|
| Operating Cash Flow | N/A | $1.27B |
| Capital Expenditures | $-29.67M | N/A |
| Free Cash Flow | $88.44M | $-677.00M |
| Debt Repayment | N/A | $-505.00M |
| Common Stock Repurchase | N/A | $-300.00M |
Short Interest & Institutional Ownership Analysis
| Metric | ERIE | MMC |
|---|---|---|
| Shares Short | 1.75M | 5.98M |
| Short Ratio | 11.61 | 2.21 |
| Short % of Float | 0.07% | 0.01% |
| Average Daily Volume (10 Day) | 135,263 | 2,292,330 |
| Average Daily Volume (90 Day) | 143,881 | 2,608,213 |
| Shares Outstanding | 52.29M | 491.40M |
| Float Shares | 19.54M | 490.71M |
| % Held by Insiders | 0.45% | 0.00% |
| % Held by Institutions | 0.52% | 0.93% |
Dividend Analysis & Yield Comparison: Erie Indemnity vs Marsh & McLennan
| Metric | ERIE | MMC |
|---|---|---|
| Last 12-Month Dividend | $6.71 | $3.24 |
| Last 12-Month Dividend Yield | 1.86% | 1.51% |
| 3-Year Avg Annual Dividend | $5.46 | $2.58 |
| 3-Year Avg Dividend Yield | 0.40% | 0.36% |
| 3-Year Total Dividends | $16.39 | $7.73 |
| Ex-Dividend Date | Oct 06, 2025 | Apr 03, 2025 |